Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
Sabine Eichinger, Professor at Wien Medicine University, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Blood, adding:
”Is recurrence risk after provoked VTE really low?
Our new study in Blood Blood Journal challenges this long-standing assumption.
In a prospective cohort of 242 patients with VTE provoked by transient risk factors, we found substantial differences in recurrence risk after discontinuation of anticoagulation.
At 2 years, recurrence risk was:
9.5 percent overall
- 19.7 percent after major transient risk factors, particularly major surgery
- 5.0 percent after minor transient risk factors
- 0 recurrences among 81 women with VTE associated exclusively with combined hormonal contraceptive use
These findings challenge the traditional view that transiently provoked VTE uniformly carries a low recurrence risk.
The key message: ‘Provoked’ is not one risk category.
Decisions on anticoagulation duration should consider the specific provoking factor rather than relying solely on the distinction between provoked and unprovoked VTE.
Pleased to share our latest research from the Medical University of Vienna, published in Blood.”
Title: Risk of recurrence in patients with provoked venous thromboembolism: a prospective cohort study
Authors: Sabine Eichinger, Lisbeth Eischer, Alexandra Kaider, Georg Heinze, Peter Quehenberger, Paul A. Kyrle
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice
-
Nov 15, 2026, 15:03Francesco Antonio Veneziano: Rethinking Coronary Artery Disease Through Precision Cardiology
-
Nov 15, 2026, 14:37Denise Rezende: 100 Years of von Willebrand Disease and Advances in Diagnosis
-
Nov 15, 2026, 14:22Ahmed Alotaibi: Does Donor Sex Influence Platelet Storage Quality